Clinical evaluation and options for infrainguinal atherosclerosis therapy: When to intervene?

Journal of Interventional Cardiology

Volumn 14, Issue 5, 2001, Pages 529-532

  Jaff, Michael R ^a  

^a Heart and Vascular Institute of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; PENTOXIFYLLINE;

ARTERIOGRAPHY; ARTERY DISEASE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ECHOGRAPHY; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; LEG REVASCULARIZATION; MAGNETIC RESONANCE ANGIOGRAPHY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 0035159704     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2001.tb00368.x     Document Type: Conference Paper

References (34)

1. The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking, and mortality in older men and women
2. The vascular laboratory. A critical component required for successful management of peripheral arterial occlusive disease
3. Duplex scanning for diagnosis of aortolifac and femoropopiteal disease: A prospective study
4. Can duplex scanning replace arteriography for lower extremity arterial disease?
5. Duplex ultrasound scanning defines operative strategies for patients with limb-threatening ischemia
6. The use of color-coded duplex scanning in the selection of patients with lower extremity arterial disease for percutaneous transluminal angioplasty: A prospective study
7. Magnetic resonance angiography in the management of lower extremity arterial occlusive disease: A prospective study
8. Stenting of the iliac arteries with the Palmaz stent: Experience from a multicenter trial
9. Percutaneous transluminal angioplasty and primary stenting of the iliac arteries in 288 patients
10. Percutaneous endoluminal treatment of iliac occlusions: Long-term follow-up in 105 patients
11. Complications of iliac artery stent deployment
12. Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia
13. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty
14. Femoropopliteal stent placement: Long-term results
15. Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease
16. Percutaneous transluminal angioplasty of the infrapopliteal vessels: The evidence
17. Should percutaneous transluminal angioplasty be recommended for treatment of infragenicluate popliteal artery or tibioperoneal trunk stenosis?
18. Is intermittent claudication improved by percutaneous transluminal angioplasty?
19. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review
20. A review of the clinical effectiveness of exercise therapy for intermittent claudication
21. Physical training of patients with intermittent claudication: Indications, methods, and results
22. Vascular rehabilitation: Benefits of a structured exercise risk modification program
23. Value of a supervised exercise program for the therapy of arterial claudication
24. Exercise training improves functional status in patients with peripheral arterial disease
25. Intensive vascular training in peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E or intravenous line during training
26. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response
27. Exercise rehabilitation programs for the treatment of claudication pain
28. Drug treatment of intermittent claudication: A critical analysis of the methods and findings of published clitical trials, 1965-1985
29. Pharmacologic treatment of intermittent claudication
30. Management of intermittent claudication with pentoxifyline: Meta-analysis of randomized controlled trials
31. Cilostazol has beneficial effects in treatment of intermittent claudication
32. Two doses of cilostazol versus placebo in the treatment of claudication: Results of a randomized, multicenter trial
33. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
34. Cilostazol or pentoxidyline for claudication?